Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean puntoni o (1 results)?
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study.
Provenzano L, Dieci MV, Curigliano G, Giuliano M, Botticelli A, Lambertini M, Rizzo G, Pedersini R, Sirico M, La Verde N, Gennari A, Zambelli A, Toss A, Piras M, Giordano M, Tagliaferri B, Generali D, Sartori D, Miliziano D, Menichetti A, Ligorio F, Zurlo C, Griguolo G, Berton Giachetti PP, Faso V, Corti C, Chiappe E, Scagnoli S, Pisegna S, Capasso C, De Angelis C, Arpino G, Criscitiello C, Guarneri V, Pruneri G, Mariani L, Vernieri C; PALMARES-2 Study Group. Provenzano L, et al. Ann Oncol. 2025 Jul;36(7):762-774. doi: 10.1016/j.annonc.2025.03.023. Epub 2025 Apr 8. Ann Oncol. 2025. PMID: 40204155 Free article.
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.
Canino F, Barbolini M, De Giorgi U, Fontana T, Gaspari V, Gianni C, Gianni L, Maestri A, Minichillo S, Moscetti L, Mura A, Nicoletti SVL, Omarini C, Pagani R, Sarti S, Toss A, Zamagni C, Cuoghi Costantini R, Caggia F, Antonelli G, Baglio F, Belluzzi L, Martinelli G, Natalizio S, Ponzoni O, Dominici M, Piacentini F. Canino F, et al. Among authors: ponzoni o. BMC Cancer. 2024 Jun 15;24(1):735. doi: 10.1186/s12885-024-12506-0. BMC Cancer. 2024. PMID: 38879498 Free PMC article.
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes.
Omarini C, Catani V, Mastrolia I, Toss A, Banchelli F, Isca C, Medici D, Ponzoni O, Brucale M, Valle F, Baschieri MC, D'Amico R, Masciale V, Chiavelli C, Caggia F, Bortolotti CA, Piacentini F, Dominici M. Omarini C, et al. Among authors: ponzoni o. Biomark Res. 2025 Jan 23;13(1):14. doi: 10.1186/s40364-025-00724-y. Biomark Res. 2025. PMID: 39849610 Free PMC article.
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes.
Barbieri E, Venturelli M, Mastrodomenico L, Piombino C, Ponzoni O, Zaniboni S, Barban S, Razzaboni E, Grandi G, Dominici M, Cortesi L, Toss A. Barbieri E, et al. Among authors: ponzoni o. Tumori. 2024 Nov 21:3008916241274721. doi: 10.1177/03008916241274721. Online ahead of print. Tumori. 2024. PMID: 39568367
Management of PALB2-associated breast cancer: A literature review and case report.
Toss A, Ponzoni O, Riccò B, Piombino C, Moscetti L, Combi F, Palma E, Papi S, Tenedini E, Tazzioli G, Dominici M, Cortesi L. Toss A, et al. Among authors: ponzoni o. Clin Case Rep. 2023 Aug 22;11(8):e7747. doi: 10.1002/ccr3.7747. eCollection 2023 Aug. Clin Case Rep. 2023. PMID: 37621724 Free PMC article.
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.
Canino F, Tornincasa A, Bettelli S, Manfredini S, Barbolini M, Moscetti L, Omarini C, Toss A, Tamburrano F, Antonelli G, Baglio F, Belluzzi L, Martinelli G, Natalizio S, Ponzoni O, Dominici M, Piacentini F. Canino F, et al. Among authors: ponzoni o. Int J Mol Sci. 2024 Feb 20;25(5):2490. doi: 10.3390/ijms25052490. Int J Mol Sci. 2024. PMID: 38473737 Free PMC article.